Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Haemonetics Corp HAE

Healthcare Medical Instruments & Supplies

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma... see more

Add To Watchlist

Recent & Breaking News (NYSE:HAE)

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

PR Newswire October 6, 2021

Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

PR Newswire September 30, 2021

Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference

PR Newswire August 25, 2021

Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website

PR Newswire August 11, 2021

ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics' Persona Technology for NexSys Plasma Collection System

GlobeNewswire August 10, 2021

Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as New Board Chair

PR Newswire August 9, 2021

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021

PR Newswire July 9, 2021

Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

PR Newswire May 13, 2021

Peer-Reviewed Results of Haemonetics' Improving Plasma Collection (IMPACT) Trial Published in the Journal TRANSFUSION

PR Newswire April 29, 2021

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021 Results: May 13, 2021

PR Newswire April 23, 2021

Haemonetics Provides Update On U.S. Plasma Business

PR Newswire April 19, 2021

Haemonetics Prices $435.0 Million Convertible Senior Notes Offering

PR Newswire March 2, 2021

Haemonetics Announces Proposed Convertible Senior Notes Offering

PR Newswire March 1, 2021

Haemonetics To Present At The Jefferies Plasma Summit

PR Newswire February 26, 2021

Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

PR Newswire February 2, 2021

Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic

PR Newswire January 22, 2021

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

PR Newswire January 20, 2021

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2021 Results: February 2, 2021

PR Newswire January 5, 2021

Haemonetics 2nd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

PR Newswire November 4, 2020

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2021 Results: November 4, 2020

PR Newswire October 6, 2020